Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Creighton University Forest Laboratories |
---|---|
Information provided by: | Creighton University |
ClinicalTrials.gov Identifier: | NCT00590642 |
This study examines the use of Acamprosate (Campral(R)) in the treatment of Obsessive Compulsive Disorder (OCD). The treatment of this condition is difficulty and a large percentage of patients fail to respond to medications and have residual symptoms. Such patients are referred to as having treatment resistant OCD.
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | Augment in Treatment-Resistent Obsessive-Compulsive Disorder: an Open-Label Trial |
Estimated Enrollment: | 30 |
Study Start Date: | April 2006 |
Estimated Study Completion Date: | March 2010 |
Estimated Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |
A patient will receive study drug for about 12 weeks. Throughout the study, the study doctor, on best medical judgment, may gradually increase or decrease the dose of the study medication. The adjustments will dependent on the subject's response and whether the subject has side effects. Once the subject has completed treatment under this study, the subject may resume standard treatment for his/her obsessive compulsive disorder by their regular doctor.
Ages Eligible for Study: | 19 Years to 55 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Psychiatry clinic
Inclusion Criteria:
Exclusion Criteria:
Contact: Angela Greer, BS | 402-345-8828 ext 21 | angelagreer@creighton.edu |
Contact: Wendy S Taylor | 402-345-8828 ext 20 | wtaylor@creighton.edu |
United States, Nebraska | |
Creighton University Department of Psychiatry | Recruiting |
Omaha, Nebraska, United States, 68131 | |
Principal Investigator: Sriram Ramaswamy, MD | |
Sub-Investigator: Daniel R Wilson, MD, PhD | |
Sub-Investigator: Frederick S Petty, MD, PhD | |
Sub-Investigator: William Marcil, MD | |
Sub-Investigator: S F Qadri, MD |
Principal Investigator: | Sriram Ramaswamy, MD | Creighton University |
Responsible Party: | Creighton University ( Sriram Ramaswamy, M.D. ) |
Study ID Numbers: | CMP-MD-14 |
Study First Received: | December 11, 2007 |
Last Updated: | April 16, 2009 |
ClinicalTrials.gov Identifier: | NCT00590642 History of Changes |
Health Authority: | United States: Institutional Review Board |
obsessive compulsive disorder OCD treatment-resistant SSRI |
Anxiety Disorders Mental Disorders Serotonin Uptake Inhibitors Obsessive-Compulsive Disorder |
Pathologic Processes Disease Anxiety Disorders Mental Disorders Obsessive-Compulsive Disorder |